Sangam Health Care Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited financial ....
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its Board meeting is scheduled for 29 May 2026 to consider and approve the audited financial results for Q4 and the financial year ended 31 March 2026, along with the audit report for the same period. This is a standard pre-meeting intimation filed under SEBI regulations and does not contain any actual financial figures or commentary. The company will hold the meeting at its registered office, with any other business to be taken up with the Chair's permission. Managing Director D. Bhagat Reddy has signed the intimation.
This is a routine procedural filing with no immediate shareholder impact. The actual financial results and any significant findings from the audit report will be disclosed after the meeting.